Skip Navigation

European Heart Journal 1993 14(Supplement E):120-127; doi:10.1093/eurheartj/14.suppl_E.120
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Trappe, H.-J.
Right arrow Articles by Lichtlen, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trappe, H.-J.
Right arrow Articles by Lichtlen, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The European Society of Cardiology

Role of interventional therapy in patients with coronary heart disease and life-threatening ventricular tachyarrhythmias

H.-J. Trappe*,, H. Klein*, P. Wenzlaff*, H.-G. Fieguth{dagger}, T. Wahlers{dagger}, B. Kielblock and P. R. Lichtlen*

* Departments of Cardiology, University Hospital Hannover Germany
{dagger} Departments of Cardiovascular Surgery, University Hospital Hannover Germany

Correspondence: Dr Hans-Joachim Trappe. Department of Cardiology. University Hospital Hannover. Konstanly-Gutschow-Str. 8. 3000 Hannover 61, Germany.

This study includes 357 patients with coronary heart disease and life-threatening ventricular tachyarrhythmias. Thirty-three atients (10%) underwent direct current (DC) catheter ablation (group 1), 121 (34%) mapping-guided surgery (group 2) and 203 (56%) received an implantable cardioverter defibrillator (ICD) (group 3). The mean follow-up was 35 ± 25 months in group I, 41 ± 37 months in group 2 and 22 ± 22 months in group 3. During follow-up, 6 patients (18%) died in group 1, 45 (37%) in group 2 and 46 (23%) in group 3. Sudden death occurred in two patients (6%) in group I, 10 patients (8%) in group 2 and eight patients (4%) in group 3. Non-fatal recurrences group were observed in 19 patients (57%) in group 1 andin 16 patients (14%) in group 2. ICD discharges occurred in 175/203 patients (86%) in group 3 with a mean number of 18 ± 28 ICD shocks per patient. Our data show that catheter ablation has a low incidence of sudden death but a high incidence of non-fatal recurrences. Mapping-guided surgery yields low rates of sudden death or recurrence. Patients with an ICD have a low sudden death rate. A treatment algorithm is necessary to evaluate patients at high risk for sudden death and to choose the right patient for the right treatment.

Key Words: Ventricular tachyarrhythmias • catheter ablation • mapping guided surgery • implantable cardioverter/defibrillator


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.